Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Holbæk

36 clinical trials in Holbæk, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Holbæk at a glance
36
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

36 trials in Holbæk

Open in trial search
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Rocuronium Bromide
  • Sponsor:Nordsjaellands Hospital
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ferric Derisomaltose
  • Sponsor:Pharmacosmos A/S

Other cities in Denmark

The busiest research cities in the country

All 47 cities in Denmark

Clinical research in Holbæk

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking studies focusing on heart failure prevention and innovative treatments for atrial fibrillation. Multiple trials are evaluating new therapeutic combinations and medications for improved patient outcomes.

  • Heart Failure Management
  • Stroke Prevention
  • Cardiac Arrest Treatment

Research includes novel approaches using baxdrostat and dapagliflozin combinations for heart failure risk reduction.

02 Kidney Disease Studies

Comprehensive research into chronic kidney disease treatments, particularly focusing on patients with concurrent hypertension. Studies examine innovative therapeutic approaches for non-diabetic kidney disease.

  • CKD Progression
  • Hemodialysis Treatments
  • Renal Function Protection

Trials investigate combined therapies to slow disease progression and improve patient outcomes.

03 Metabolic Disorders

Innovative trials addressing obesity management in different age groups, with special attention to adolescent populations. Studies also focus on diabetes treatment approaches.

  • Weight Management Therapies
  • Type 1 & 2 Diabetes
  • Metabolic Interventions

Research includes novel treatments with semaglutide for weight management in young populations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.